missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Cyclobenzaprine.HCl, Lipomed
Description
Cyclobenzaprine.HCl
Specifications
Specifications
| Kemiskt namn eller material | Cyclobenzaprine Hydrochloride |
| CAS | 6202-23-9 |
| Analyt- eller komponentnamn | Cyclobenzaprine Hydrochloride |
| Frakt skick | Rumstemperatur |
| Molekylformel | C20 H21 N . Cl H |
| Synonym | Amitriptyline Hydrochloride Imp. B (EP), Amitriptyline Imp. B (EP), Nortriptyline Hydrochloride Imp. E (EP), Nortriptyline Imp. E (EP), Cyclobenzaprine Hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride, 10,11 delta-Amitriptyline hydrochloride |
| InChI formel | InChI=1 S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18 H,10-11H2,1-2H3;1 H |
| LEDER | Cl.CN(C)CCC=C1c2ccccc2C=Cc3ccccc13 |
| IUPAC-namn | 3-(dibenzo[2,1-b:1',2'-e][7 ]annulen-11-yliden)-N,N-dimetylpropan-1-amin; hydroklorid |
| Industry Type | Farmaceutisk |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?